Endoscopy 2003; 35(1): 61-67
DOI: 10.1055/s-2003-36414
Original Article
© Georg Thieme Verlag Stuttgart · New York

Even Young Patients with No Alarm Symptoms Should Undergo Endoscopy for Earlier Diagnosis of Gastric Cancer

H.  Bołdys1 , T.  A.  Marek1 , P.  Wanczura1 , P.  Matusik1 , A.  Nowak1
  • 1Department of Gastroenterology, Silesian University School of Medicine, Katowice, Poland
Further Information

Publication History

Received: 3 July 2001

Accepted after Revision: 7 October 2002

Publication Date:
02 January 2003 (online)

Background and Study Aims: There has been a tendency in recent years to omit endoscopy in dyspeptic patients younger than 45 years with no so-called “alarm symptoms.” This study was conducted to test whether this policy might lead to an increased rate of delayed diagnosis of gastric cancer, especially in a population with a high prevalence of the disease.
Patients and Methods: The study included 860 patients (465 women, 395 men; median age 44) referred for the first time for upper gastrointestinal endoscopy because of suspected upper gastrointestinal pathology, to a secondary referral center between 1983 and 1993. Symptoms were assessed using a special questionnaire prior to endoscopy. The endoscopic diagnosis was always confirmed by histology.
Results: Gastric cancer was found in 83 patients (12 early cancers, 71 advanced). Patients with cancer were predominantly male (68 %, compared with 44 % in the no-cancer group; P < 0.001), and significantly older (median age 56, 44 and 42 years for advanced, early cancer, and no cancer, respectively; P < 0.001). As many as 24 % of patients with cancer were aged under 45 years. Symptoms occurring more frequently in the gastric cancer group compared with the no-cancer group were weight loss (11 % vs. 0.1 %; P < 0.001), gastrointestinal bleeding (18 % vs. 8 %; P < 0.001), anorexia (43 % vs. 25 %; P < 0.001), and fatigue (53 % vs. 30 %; P < 0.001). In 27 % of cancer patients none of the above symptoms was observed. No statistical difference was seen for pain, nausea, vomiting, and other symptoms. The mean symptom score (1 point for one symptom) was higher in patients with cancer compared with those without (3.1 vs. 2.4; P < 0.001). The duration score (1 to 4 points for durations of less than 6, less than 12, less than 24, and more than 24 months) was lower (1.3 vs. 1.8; P < 0.001) in cancer patients. In three-quarters of cancer patients the duration of symptoms was shorter than 6 months.
Conclusions: Symptoms suggesting gastric cancer are gastrointestinal bleeding, weight loss, and to a lesser degree anorexia and fatigue. Gastric cancer patients show a greater intensity but shorter duration of symptoms than patients with no cancer. Age and alarm symptoms cannot determine the need for upper gastrointestinal endoscopy, at least in areas of high prevalence of gastric cancer.

References

  • 1 Fielding J WL, Rogiński C, Ellis D J. et al . Clinico-pathological staging of gastric cancer.  Br J Surg. 1974;  71 677-680
  • 2 Sue-Ling H M, Johnston D, Martin I G. et al . Gastric cancer: a curable disease in Britain.  BMJ. 1993;  303 591-596
  • 3 Martin I G, Young S, Sue-Ling H, Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series.  BMJ. 1997;  314 467-471
  • 4 Hosokawa O, Tsuda S, Kidani E. et al . Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy.  Endoscopy. 1998;  30 669-674
  • 5 Axon A TR. Chronic dyspepsia: who needs endoscopy?.  Gastroenterology. 1998;  112 1376-1380
  • 6 American G astroenterological . American Gastroenterological Association medical position statement: evaluation of dyspepsia.  Gastroenterology. 1998;  114 579-581
  • 7 Christie J, Shepherd A, Codling B W, Valori R M. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia.  Gut. 1997;  41 513-517
  • 8 Bray F, Sankila R, Ferlay J, Parkin D M. Estimates of cancer incidence and mortality in Europe in 1995.  Eur J Cancer. 2002;  38 99-166
  • 9 Black R J, Bray F, Ferlay J, Parkin D M. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidences for 1990.  Eur J Cancer. 1997;  33 1075-1107
  • 10 Williams B, Luckas M, Ellingham J H. et al . Do young patients with dyspepsia need investigation?.  Lancet. 1988;  ii 1349-1355
  • 11 Briggs A H, Sculpher M J, Logan R PH. et al . Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.  BMJ. 1996;  312 1321-1325
  • 12 Everett S M, Axon A TR. Early gastric cancer in Europe.  Gut. 1997;  41 142-150
  • 13 Talley N J, Colin-Jones D, Koch K L. et al . Functional dyspepsia: a classification with guidelines for diagnosis and management.  Gastroenterol Int. 1991;  4 145-160
  • 14 Bramble M G, Suvakovic Z, Hungin A PS. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy.  Gut. 2002;  46 464-467
  • 15 Bini E J, Lascarides C E, Weinshel E H. Early detection of colorectal cancer in iron-deficient patients: don’t wait for the anemia [abstract].  Gastrointest Endosc. 2001;  53 AB178
  • 16 Nahon S, Nahon-Uzan K, Lahmek P. et al . Evaluation of the gastro-intestinal tract in pre- and post-menopausal women with idiopathic iron-deficiency anemia: transversal study of 241 women [abstract].  Gastrointest Endosc. 2001;  53 AB193
  • 17 Talley N J, Silvertein M D, Agreus L. et al . AGA technical review: evaluation of dyspepsia.  Gastroenterology. 1998;  114 582-59
  • 18 Lim A G, Martin R M, Montileone M. et al . Helicobacter pylori serology and the management of young dyspeptics: a UK survey of gastroenterologists and general practitioners with an interest in gastroenterology.  Aliment Pharmacol Ther. 1997;  11 299-303

H. Bołdys, M.D.

Department of Gastroenterology, Silesian University School of Medicine ·

ul. Medyków 14 · 40-752 Katowice · Poland

Fax: + 48-32-2523119

Email: hubol@mp.pl

    >